| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Horizon Therapeutics Public Ltd Co | EVP, General Counsel | Ordinary Shares | 62,775 | $7,313,288 | $116.50 | 17 Sep 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000120919121056671-beeler-brian-k-2021-09-17 | Horizon Therapeutics Public Ltd Co | 17 Sep 2021 | 1 | -$3,036,911 | 4 | EVP, General Counsel | 17 Sep 2021, 17:06 |
| /report/000120919121051912-beeler-brian-k-2021-08-16 | Horizon Therapeutics Public Ltd Co | 16 Aug 2021 | 3 | -$6,481,114 | 4 | EVP, General Counsel | 17 Aug 2021, 17:01 |
| /report/000120919121048786-beeler-brian-k-2021-07-28 | Horizon Therapeutics Public Ltd Co | 28 Jul 2021 | 3 | -$263,732 | 4 | EVP, General Counsel | 30 Jul 2021, 16:23 |